Max Healthcare Q4FY26: Profit up 7%, stock drops 7%

Stock falls despite a positive broader market

Max Healthcare Institute shares fell more than 7% on May 22, 2026, after the company reported January to March (Q4FY26) earnings that were below expectations. The stock touched an intraday low of ₹1,011.30 on the NSE. Around 11:10 AM, it was trading at ₹1,024.60, down 6.1% versus the previous close of ₹1,091. In contrast, the Nifty50 was up 0.49% at 23,771. The stock was also described as the worst hit among Nifty 50 constituents during the session.

What the company reported for Q4FY26

In the March 2026 quarter, Max Healthcare reported consolidated revenue from operations of ₹2,142.89 crore, up 12.2% from ₹1,909.74 crore a year earlier. Total income stood at ₹2,190.72 crore, up 12% from ₹1,956.66 crore. Consolidated net profit rose 7.27% year-on-year to ₹342.22 crore, compared with ₹319.00 crore in the corresponding quarter last year. Another report also cited profit after tax at ₹387 crore for the quarter ended March 31, 2026.

Why the results were seen as a miss

Wire reports said Max Healthcare’s consolidated net profit and revenue were “sharply below the Street’s expectations”. For Q4FY26, analysts’ expectations cited in the report were net profit of ₹439 crore and revenue of ₹2,633 crore, compared with the reported ₹342 crore profit and about ₹2,143 crore revenue. The company’s expenses rose at a double-digit pace, and its average bed occupancy rate was described as unchanged, factors that weighed on the quarter’s performance. Separately, a summary note said Q4 revenue rose 10.2%, which was below Motilal Oswal’s forecast.

Trading snapshot: price levels and volumes

The decline played out amid heavier trading activity. Nearly 4 million shares were reported to have changed hands on the NSE by about 10:07 IST, versus over 1 million shares traded by the same time the previous day. The stock was quoted at ₹1,021.05 at 10:07 IST, down over 6%. Data in the coverage also referenced a price of about ₹1,030 for May 22, 2026, underscoring intraday volatility.

Relative performance: YTD versus the index

Despite the sharp one-day drop, the stock’s year-to-date performance in 2026 was described as positive. Max Healthcare shares were up over 4% on a YTD basis, while the Nifty50 index was down 9.5% over the same period. Sector sentiment on the day appeared mixed, with the Nifty500 Healthcare Index quoted at 20,260.2, down about 0.80%.

Operational indicators mentioned in the reports

Operationally, the quarter was impacted by a rise in expenses and an unchanged average bed occupancy rate, according to the wire copy. Another earnings highlight noted that network gross revenue stood at ₹2,664 crore, up 10% year-on-year, driven mainly by higher occupied bed days (OBDs). International patient revenue increased 12% year-on-year to ₹227 crore and contributed around 9% of hospital revenue.

Expansion plans flagged alongside the results

The coverage also noted future capacity plans. Max Healthcare was reported to be building new hospitals in Gurgaon and Lucknow. While the immediate market reaction focused on the Q4 miss versus expectations, these projects provide context for ongoing spending and capacity addition.

Key numbers at a glance

Market impact: what changed for investors on the day

The sharp fall reflected a gap between reported numbers and what the market had priced in, especially on profit and revenue versus expectations cited in the wire report. Higher expenses and the lack of improvement in average bed occupancy were key negatives highlighted in the coverage. The stock’s decline stood out because it came on a day when the broader market was higher, with the Nifty50 up 0.49%.

Analysis: why the print mattered

The Q4FY26 results showed continued double-digit growth in revenue and total income, but the market’s reaction suggested sensitivity to margins and forecast risk. A 7% rise in profit alongside commentary on expense growth and unchanged occupancy reinforced the “margin pressure” framing. For a hospital operator, such operating metrics can influence quarterly profitability even when revenue trends remain positive.

Conclusion

Max Healthcare’s Q4FY26 results delivered higher year-on-year revenue and profit, but the numbers were reported as below Street expectations, triggering a 7% intraday fall. Investors will likely track how expenses and occupancy trends evolve, alongside the company’s hospital expansion plans in Gurgaon and Lucknow.